Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This article reviews maternal-fetal outcomes in patients with gestational diabetes and COVID-19 through a case study and literature analysis but reports no new clinical results.

This study found that topical application of a cosmetic formulation containing capryloyl glycine 4% significantly reduced hair growth and thickness on the forearms of female participants after 120 days, compared to placebo.

This article discusses thallium poisoning and its diagnosis, symptoms, and treatment options, emphasizing the need for awareness due to its misleading symptoms and potential for misdiagnosis.

In this study, patient-reported outcomes indicated that greater weight loss with GLP-1RA treatments was associated with increased reports of adverse cosmetic effects such as skin laxity, facial volume loss, and hair shedding, despite improvements in some preexisting inflammatory skin conditions.

This narrative review suggests that the association between weight-loss medications and telogen effluvium is primarily due to metabolic changes from rapid weight loss, rather than a direct pharmacological effect on hair follicles.

In this study, Brazilian dermatologists reported that patients with alopecia areata, particularly those with severe scalp hair loss, often experience an unmet need for advanced therapies that could improve treatment outcomes beyond the limitations of current options.

This study reported that obese women with polycystic ovary syndrome had higher body fat and insulin resistance, and lower HDL cholesterol compared to non-obese patients and healthy controls.

This study found that a topical formulation containing DMG-Na significantly improved hair loss parameters in people experiencing hair loss, suggesting its potential effectiveness for such conditions.

This review highlights the significant relationship between dermatological disorders and cardiovascular risk, suggesting that reducing systemic inflammation may help mitigate cardiovascular complications in affected patients.

This study found that among Australians aged 15 and older, the lifetime prevalence of alopecia areata ranged from 1.2% to 2.3%, and the point prevalence ranged from 0.9% to 1.4%, emphasizing the need for better awareness and education about treatment options.

This case study describes a 34-year-old male developing painful inflammatory scalp nodules post-scalp microinfusion of medication. The findings suggest that repeated microtrauma or bacterial colonization might trigger dissecting cellulitis in susceptible individuals, with exogenous testosterone as a potential modifier, not a direct cause.

This review discusses the potential and current limitations of regenerative therapies like PRP and stem cells in dermatology, highlighting the need for more clinical trials to standardize protocols and optimize outcomes.

This case report highlights a rare occurrence of squamous cell carcinoma developing at the site of synthetic hair implantation many years later, emphasizing the need for vigilance when examining chronic scalp lesions in patients with such procedures.

This study developed consensus guidelines for using low-dose oral and topical minoxidil in patients undergoing hair transplant surgery for pattern hair loss, recommending dosing adjustments, monitoring protocols, and timing for post-surgery application.

This consensus provides a framework for standardized diagnosis and treatment of alopecia areata in the Asia Pacific region, recommending specific therapies based on age and disease severity.

This study found that, although finasteride reduced dihydrotestosterone levels in males with heavy episodic drinking, it did not significantly alter brain activation or craving but was linked to a stronger desire not to drink.

This study concluded that hair loss is a common issue after vertical sleeve gastrectomy, influenced by serum leucine concentration, and is not typically due to low iron or zinc levels.

In this study, lower dihydrotestosterone and higher testosterone levels were linked to increased brain activation during response inhibition, although no behavioral changes were detected.

This study reports that targeting both hair follicles and surrounding tissue offers a safe and significantly beneficial improvement in androgenetic alopecia symptoms, with advanced dermocosmetics playing a crucial role alongside traditional pharmacological interventions in long-term management.

This case report found that hyperbaric oxygen therapy significantly accelerated postoperative recovery in hair transplantation patients, improving healing, graft integration, and patient satisfaction without complications.

In this update, researchers incorporated TGA-approved Janus Kinase inhibitors into the Australian treatment guidelines for chronic, moderate to severe Alopecia areata, aiming to enhance recommended therapies by providing guidance on the use and management of these systemic medications.

This study found that topical treatment with 7DHC and BM15766 reduced hair growth in mice compared to those treated with Ethanol/DMSO, and hair did not recover after treatment ceased, alongside increased apoptotic cells and decreased expression of specific genes.

This study observed that treating hair follicles with BM15766 and 7DHC led to structural damage, disrupted cellular organization, reduced expression of key genes and proteins, and increased apoptosis, in contrast to controls, indicating detrimental effects on hair follicle integrity.

This Mendelian randomization study found that specific dietary patterns, such as consuming antioxidant-rich foods like melon and tea, may have protective effects against hair loss, while processed carbohydrates, alcohol, and certain dairy products could increase the risk of androgenetic alopecia and alopecia areata.

This source presents an expert consensus framework for determining which Australian patients with alopecia areata should receive subsidized JAK inhibitor therapy, emphasizing the need for future research including patient perspectives to enhance criteria, ensure fair treatment access, and evaluate real-world outcomes.

In this study, a DMG-Na and caffeine-containing shampoo significantly reduced hair loss and increased hair density in men with male pattern hair loss over 6 months, compared to a placebo, without adverse effects.

The Brazilian version of the Alopecia Areata Quality of Life Index is reliable for assessing patients' quality of life.

This study found that the peptide TSN6 increased epidermal thickness and promoted hair follicle formation in dermal–epidermal composites grafted onto nude mice, with TSN6-treated composites showing more hair follicles and retained grafts compared to control groups.

This study highlighted the potential of iron chelators, deferoxamine and deferiprone, to improve hair density, thickness, and elasticity and reduce hair loss by up to 66.8% over six months in individuals with autoimmune alopecia, suggesting they may offer a promising therapeutic option.

This report discusses a 48-year-old patient with androgenetic alopecia and basal cell carcinoma on the right hairline, where forehead reduction surgery and tumor excision were performed simultaneously, improving aesthetics and resolving the cancer issue.